"Designing Growth Strategies is in our DNA"
The Middle East & Africa is the fourth largest region in the global dry eye syndrome market. It is projected to grow at a CAGR of 5.2% during the forecast period. The global market for dry eye syndrome is projected to grow from USD 6.61 billion in 2022 to USD 11.26 billion by 2030.
Growing demand for eye care products for the treatment of this condition has led market players in the region to expand their production capacity by making strategic alliances with native players. For example, in July 2020, Ntc s.r.l. granted an exclusive license and distribution rights to Taro Pharmaceuticals in Israel for its fixed combination of an ophthalmic quinolone antibiotic with an anti-inflammatory steroid in eye drops. Similar efforts from leading players for the development of innovative prescription drugs will accelerate the Middle East & Africa dry eye syndrome market size during the forecast duration.
Based on country/sub-region, our report on the Middle East & Africa dry eye syndrome market covers the following countries/regions – GCC, South Africa, and the Rest of the Middle East & Africa.
Incorporation of Nanomedicine in Treatment May Pose Growth Potential
One of the key trends observed in the market is the rising application of nanoparticles in ocular diseases that allows targeted delivery, slow-release, and enhanced pharmacokinetics, therefore improving the bioavailability of drugs in the eyes. Nanomedicine offers ultra-small size particles, having versatility and target specificity, and has recently been widely investigated for treating this condition. Drugs formulated as nanoparticles can enhance the treatment of this condition with long-term drug release capacity and will reduce dosing frequency compared to topical treatments. The incorporation of such technologies for therapeutics in this market is expected to offer improved patient outcomes, leading to more robust patient adoption. Hence, such ongoing research and a growing pipeline for dry eye products are predicted to be a new trend for the future.
Rising Prevalence of this Condition May Propel the Market Growth
One of the positive market-impacting factors for this region’s growth is the growing prevalence of this condition, which may lead to an increase in its diagnosis rate. This is expected to drive the demand for its treatment across the region. Companies engaged in the market are focusing on making strategic initiatives to expand their product presence in this region to meet the existing demand. They are also focusing on upscaling their production capacity through the expansion of its manufacturing facility.
Request a Free sample to learn more about this report.
Limited Awareness Regarding the Condition to Limit the Market Growth
Despite the growing prevalence of this condition, one of the key factors limiting the market growth is the lack of awareness regarding the treatment options available across the region. Limiting factors in the Middle East include poor patient education concerning this condition, lack of proper general practitioner system, irregular follow-up, high rates of refractive eye surgery, high rates of contact lens wear, and environmental factors. The confluence of such factors severely limits the market growth potential. Moreover, many studies witnessed poor attitudes of the general population toward treatment related to this disease as most of them do not visit routinely to an ophthalmologist. Furthermore, the high cost of specialty dry eye products may also limit the Middle East & Africa dry eye syndrome market growth.
In the Middle East & Africa, the competitive landscape has the presence of some of the prominent players such as AbbVie, Inc., Alcon, and Novartis AG. These companies are focused on strengthening their supply and demand by upscaling their production capacity.
Some other market players include Bausch & Lomb Pvt Ltd. and Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson Vision Care, Inc., and others. These companies are focused on expanding their Middle East & Africa dry eye syndrome market share by making a strategic alliance with native players to strengthen their distribution network across the regions.
To gain extensive insights into the market, Request for Customization
The Middle East & Africa dry eye syndrome market research report provides qualitative and quantitative insights on the market and a detailed analysis of the Middle East & Africa market size & growth rate for all possible segments in the market. Along with the market overview, the report provides an elaborative impact analysis of drivers and restraints along with competitive landscape. Various key insights presented in the report are prevalence of the condition, by key countries, new product launches, reimbursement policies, regulatory scenario, healthcare industry overview, key countries, and the impact of COVID-19 on the market.
CAGR of 5.2% from 2023 to 2030
Value (USD billion)
By Product, Distribution Channel, and Country/Sub-Region
By Distribution Channel
Growing at a CAGR of 5.2%, the market will exhibit steady growth in the forecast period (2023-2030).
The rising incidence of dry eye disease across the region and increasing strategic initiatives made by market players to expand product presence are some of the major factors driving the growth of the market.
AbbVie, Inc., Alcon, Novartis AG, and Santen Pharmaceutical Co., Ltd. are the major market players in the Middle East & Africa market.
GCC dominated the market in 2022.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry